Breaking News Instant updates and real-time market news.

VUZI

Vuzix

$3.98

0.38 (10.56%)

, NFLX

Netflix

$343.54

-7.71 (-2.20%)

11:57
06/12/19
06/12
11:57
06/12/19
11:57

Vuzix supports streaming video services on Vuzix Blade Smart Glasses

Vuzix announces support of numerous streaming video services and other consumer applications on its Vuzix Blade Smart Glasses. "The 'Dads and Grads Summer Spree' promotion on the Vuzix Blade is an ideal opportunity for consumers and enterprise customers to own a Blade as it coincides with the just announced availability of popular streaming video applications including Netflix (NFLX), Amazon (AMZN) Prime Video and HBO Go. These Android based applications are now supported by the Vuzix Blade Smart Glasses and available for download from the Vuzix App Store," added the company.

VUZI

Vuzix

$3.98

0.38 (10.56%)

NFLX

Netflix

$343.54

-7.71 (-2.20%)

AMZN

Amazon.com

$1,852.83

-11.41 (-0.61%)

  • 12

    Jun

  • 13

    Jun

  • 25

    Jun

  • 10

    Jul

VUZI Vuzix
$3.98

0.38 (10.56%)

NFLX Netflix
$343.54

-7.71 (-2.20%)

06/03/19
LOOP
06/03/19
UPGRADE
Target $425
LOOP
Buy
Netflix upgraded to Buy from Hold at Loop Capital
Loop Capital analyst Alan Gould upgraded Netflix to Buy from Hold and raised his price target for the shares to $425 from $395.
06/04/19
LOOP
06/04/19
UPGRADE
Target $425
LOOP
Buy
Loop Capital upgrades Netflix to Buy, says streaming lead 'unstoppable'
Loop Capital analyst Alan Gould last night upgraded Netflix to Buy from Hold and raised his price target for the shares to $425 from $395. The streaming service closed yesterday down $6.65 to $336.63. Netflix has built an "unstoppable lead" in subscription video streaming while the company's margin opportunity is expanding as it increasingly becomes a content producer, distributor and retailer, Gould tells investors in a research note. The analyst increased his view of 2025 earnings per power from about $28 previously to $32 currently. He now sees Netflix's operating margins increasing 240 basis points per year to 2025. The stock should attract a 25 times price-to-earnings multiple, which implies potential to almost triple the market capitalization over a five- to six-year timeframe, Gould writes.
06/04/19
06/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Buy from Hold at Loop Capital with analyst Alan Gould saying Netflix has built an "unstoppable lead" in subscription video streaming while the company's margin opportunity is expanding as it increasingly becomes a content producer, distributor and retailer. 2. Wingstop (WING) upgraded to Buy from Hold at Stifel with analyst Chris O'Cull saying the company's system sales growth will remain in mid to high teens for the foreseeable future and generate higher cash flows from increased average unit volumes thanks to its national advertising and digital ordering initiatives. 3. National Beverage (FIZZ) upgraded to Neutral from Sell at UBS with analyst Sean King citing valuation. 4. Take-Two (TTWO) upgraded to Market Perform from Underperform at BMO Capital with analyst Gerrick Johnson with the threat of an economic downturn, video game stocks will be increasingly seen as "safe havens for investors." 5. Mirati Therapeutics (MRTX) upgraded to Buy from Neutral at Citi with analyst Yigal Nochomovitz saying he believes Mirati's KRAS G12Ci has potential to exceed AMG510's 50% overall response rate in non-small cell lung cancer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/11/19
EVER
06/11/19
NO CHANGE
Target $205
EVER
Outperform
Antitrust litigation presents risk to Apple App Store model, says Evercore ISI
Evercore ISI analyst Amit Daryanani noted that services will be the primary driver of future growth for Apple (AAPL), but said the shift towards services is not without risk. Pending antitrust litigation from suits brought by Pepper and Spotify could challenge Apple's App Store model while other large publishers could follow the lead of Netflix (NFLX) and circumvent subscription purchasing through an iOS device, said Daryanani . However, he thinks the financial impact, if any, from the Pepper case could take several years to materialize. While he expects litigation to remain a key debate topic on Apple, Daryanani keeps an Outperform rating on the shares with a price target of $205.
AMZN Amazon.com
$1,852.83

-11.41 (-0.61%)

06/12/19
WEDB
06/12/19
NO CHANGE
Target $100
WEDB
Outperform
GrubHub best positioned amid Amazon Restaurants shutdown, says Wedbush
Wedbush analyst Ygal Arounian notes that Amazon (AMZN) announced that it will shut down Amazon Restaurants in the U.S., which he views as further evidence that rationality is creeping into the U.S. 3P food takeout market. The analyst sees GrubHub (GRUB) as the best positioned to maintain/regain strength in this environment, as it is the only U.S. third-party takeout provider that is profitable and has always been rational in only adding LTV positive customers. Arounian reiterates an Outperform rating and $100 price target on GrubHub's shares, but adds that he sees "significant room" for multiple expansion if investors regain confidence in this sector.
06/12/19
WEDB
06/12/19
NO CHANGE
Target $155
WEDB
Outperform
Microsoft momentum not slowing down, says Wedbush
Wedbush analyst Daniel Ives believes Microsoft (MSFT) remains in an "enviable position" heading into the rest of 2019 and 2020 on the heels of its cloud success and is firing on all cylinders around its Office 365 and Azure strategic vision based on his recent checks. So far in the June quarter the analyst is seeing a "clear acceleration" of larger and more strategic enterprise cloud deals as believes "Redmond is poised to win the lion's share" of the next phase of cloud deployments versus Amazon (AMZN). The shift to cloud is a major secular trend that is significantly benefiting Microsoft in the field and should continue its momentum heading into the next 12-18 months, he contends. Ives reiterates an Outperform rating and $155 price target on Microsoft's shares.
06/12/19
BOFA
06/12/19
NO CHANGE
Target $108
BOFA
Buy
Less competition for GrubHub amid Amazon Restaurants exit, says BofA/Merrill
Amazon's (AMZN) discontinuation of its U.S. restaurant delivery service removes the threat to GrubHub (GRUB) of Amazon expanding its online food delivery business organically, BofA/Merrill analyst Nat Schindler tells investors in a research note. Schindler notes that online food delivery is a large, fragmented, and rapidly evolving market with significant capital infusion from public and private investors, and Amazon may be shifting from "build" to "partner or buy" in this market. The analyst contends that while GrubHub has lost some market share recently, he sees growth as healthy overall, and says the disconnect between rising private valuations and recent declines in GrubHub's market cap may create an opportunity.
06/12/19
KEYB
06/12/19
NO CHANGE
Target $190
KEYB
Overweight
FedEx price target lowered to $190 from $215 at KeyBanc
KeyBanc analyst Todd Fowler lowered his price target for FedEx (FDX) to $190 from $215 ahead of Q4 to reflect trade uncertainty and some impact of the non-renewal of the U.S. domestic Express contract with Amazon (AMZN), partially offset by improved Ground margins, voluntary buyout benefits, and modest Freight contribution. The analyst reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

ABBV

AbbVie

$66.64

-11.77 (-15.01%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
AbbVie falls -15.1% »

AbbVie is down -15.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

USNA

Usana

$78.92

6.515 (9.00%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
Usana rises 8.6% »

Usana is up 8.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYX

Pyxus

$16.40

2.98 (22.21%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
Pyxus rises 23.0% »

Pyxus is up 23.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$163.99

34.34 (26.49%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
Allergan rises 26.6% »

Allergan is up 26.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACST

Acasti Pharma

$1.03

0.02 (1.98%)

, AMRN

Amarin

$18.55

0.12 (0.65%)

11:59
06/25/19
06/25
11:59
06/25/19
11:59
Periodicals
Acasti Pharma mentioned positively by Seeking Alpha contributor »

Seeking Alpha contributor…

ACST

Acasti Pharma

$1.03

0.02 (1.98%)

AMRN

Amarin

$18.55

0.12 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Sep

AMAT

Applied Materials

$42.33

(0.00%)

11:55
06/25/19
06/25
11:55
06/25/19
11:55
Options
Applied Materials put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

ACER

Acer Therapeutics

$4.34

-14.83 (-77.36%)

11:52
06/25/19
06/25
11:52
06/25/19
11:52
Downgrade
Acer Therapeutics rating change  »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

KNX

Knight-Swift

$30.43

0.37 (1.23%)

11:45
06/25/19
06/25
11:45
06/25/19
11:45
Options
Knight Transportation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

11:45
06/25/19
06/25
11:45
06/25/19
11:45
General news
Breaking General news story  »

Atlanta Federal Reserve…

AMZN

Amazon.com

$1,890.97

-22.46 (-1.17%)

, MSFT

Microsoft

$134.89

-2.91 (-2.11%)

11:44
06/25/19
06/25
11:44
06/25/19
11:44
On The Fly
Microsoft slips as analyst sees stock 'materially overvalued' as Azure 'not AWS' »

Saying that Microsoft…

AMZN

Amazon.com

$1,890.97

-22.46 (-1.17%)

MSFT

Microsoft

$134.89

-2.91 (-2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

WPX

WPX Energy

$11.01

-0.02 (-0.18%)

11:35
06/25/19
06/25
11:35
06/25/19
11:35
Options
WPX Energy put volume heavy and directionally bearish »

Bearish flow noted in WPX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$51.10

-0.31 (-0.60%)

11:34
06/25/19
06/25
11:34
06/25/19
11:34
Hot Stocks
Lennar remains confident in reaching FY19 home delivery target of 50,000 homes »

Expects margins to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

LEN

Lennar

$50.94

-0.47 (-0.91%)

11:33
06/25/19
06/25
11:33
06/25/19
11:33
Earnings
Lennar sees Q3 EPS $1.25-$1.35, consensus $1.52 »

Sees Q3 new orders of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

11:30
06/25/19
06/25
11:30
06/25/19
11:30
General news
Treasury announced a $75 B batch of auctions for Thursday »

Treasury announced a $75…

ACER

Acer Therapeutics

$4.31

-14.86 (-77.52%)

11:25
06/25/19
06/25
11:25
06/25/19
11:25
Downgrade
Acer Therapeutics rating change  »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

CLDR

Cloudera

$5.53

0.005 (0.09%)

11:25
06/25/19
06/25
11:25
06/25/19
11:25
Options
Cloudera call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CODI

Compass Diversified

$19.00

0.345 (1.85%)

11:25
06/25/19
06/25
11:25
06/25/19
11:25
Conference/Events
Compass Diversified to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

UMC

UMC

$2.14

-0.01 (-0.47%)

11:23
06/25/19
06/25
11:23
06/25/19
11:23
Upgrade
UMC rating change at CLSA »

UMC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

ACER

Acer Therapeutics

$4.30

-14.87 (-77.57%)

11:18
06/25/19
06/25
11:18
06/25/19
11:18
Downgrade
Acer Therapeutics rating change at Needham »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

IBKR

Interactive Brokers

$52.52

0.07 (0.13%)

, ETFC

E-Trade

$44.03

-0.54 (-1.21%)

11:17
06/25/19
06/25
11:17
06/25/19
11:17
Conference/Events
Sandler O'Neill financial analyst to hold an analyst/industry conference call »

Financial Analyst Repetto…

IBKR

Interactive Brokers

$52.52

0.07 (0.13%)

ETFC

E-Trade

$44.03

-0.54 (-1.21%)

SCHW

Charles Schwab

$39.09

-0.06 (-0.15%)

AMTD

TD Ameritrade

$47.90

-0.19 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 23

    Jul

  • 06

    Aug

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
06/25/19
06/25
11:17
06/25/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
06/25/19
06/25
11:16
06/25/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTR

Dollar Tree

$110.51

-2.21 (-1.96%)

11:15
06/25/19
06/25
11:15
06/25/19
11:15
Options
Dollar Tree put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$16.24

-0.34 (-2.05%)

11:05
06/25/19
06/25
11:05
06/25/19
11:05
Options
Petrobras call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

RDS.B

Royal Dutch Shell

$66.83

0.04 (0.06%)

11:02
06/25/19
06/25
11:02
06/25/19
11:02
Conference/Events
Royal Dutch Shell management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.